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Article focus
  This study aimed to evaluate the diagnos-
tic performance of molecular and culture 
techniques in S. aureus screening, deter-
mine the cause of any discrepancy 
between the diagnostic techniques; and 
model the potential effect of different 
diagnostic techniques on S. aureus detec-
tion in orthopaedic patients.
Key messages
  The prevalence of MSSA nasal coloniza-
tion was found to be between 22.4% and 
35.6%.
  Polymerase chain reaction or preplating 
broth enrichment of swabs for culture 
can significantly improve nasal MSSA 
detection.
  use of optimal techniques could prevent up 
to 8000 MSSA SSIs per annum in the united 
States and united Kingdom combined.
Strengths and limitations
  This study provides the first evaluation of 
the effect that different diagnostic meth-
ods have on the prevalence of nasal MSSA 
colonization in an elective orthopaedic 
population.
Underestimation of staphylococcus aureus 
(MRsA and MssA) carriage associated  
with standard culturing techniques 
oNe ThIrd of carrIerS mISSed
Objectives
nasal carriers of Staphylococcus (S.) aureus (MRSA and MSSA) have an increased risk for 
healthcare-associated infections. There are currently limited national screening policies for 
the detection of S. aureus despite the World Health organization’s recommendations. This 
study aimed to evaluate the diagnostic performance of molecular and culture techniques 
in S. aureus screening, determine the cause of any discrepancy between the diagnostic 
 techniques, and model the potential effect of different diagnostic techniques on S. aureus 
detection in orthopaedic patients.
Methods
paired nasal swabs for polymerase chain reaction (pcR) assay and culture of S. aureus were 
collected from a study population of 273 orthopaedic outpatients due to undergo joint 
arthroplasty surgery.
Results
The prevalence of MSSA nasal colonization was found to be between 22.4% to 35.6%. The 
current standard direct culturing methods for detecting S. aureus significantly underesti-
mated the prevalence (p = 0.005), failing to identify its presence in approximately one-third 
of patients undergoing joint arthroplasty surgery.
Conclusion
Modelling these results to national surveillance data, it was estimated that approximately 
5000 to 8000 S. aureus surgical site infections could be prevented, and approximately 
$140 million to $950 million (approximately £110 million to £760 million) saved in treat-
ment costs annually in the United states and United Kingdom combined, by using alterna-
tive diagnostic methods to direct culture in preoperative S. aureus screening and eradication 
programmes.
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  The main limitation of this study was that Pcr-
negative samples were not analyzed in the cohort of 
samples undergoing enrichment, preventing a com-
plete evaluation of the enrichment technique.
Introduction
healthcare-associated infection is a significant clinical 
issue, particularly surgical site infection (SSI). SSI is widely 
used as a quality indicator in healthcare systems and 
reporting is mandatory in many settings, notably by 
Surgical Site Infection Surveillance Service (SSISS) from 
Public health england1 and through the center for disease 
control (cdc) in the united States.2 orthopaedic surgery 
is a primary focus of SSI surveillance, given the very high 
rates of implant surgery and the major impact that SSI can 
have on patients’ health-related quality of life, function, 
healthcare costs, and medicolegal implications.3
The reported SSI incidence for knee and hip arthro-
plasties undertaken in developed nations has been esti-
mated to be between 0.5% and 2%, based on inpatient, 
readmission episodes, and the number of revision pro-
cedures that are performed.4-8 however, even national 
surveillance estimates may under-report the true inci-
dence.9 The available data suggests that downward 
trends have levelled off, although rates for knee surgery 
may be rising.8 This could reflect a changing prevalence 
of risk factors for infection, such as revision surgery, 
longer operation times, higher BmI, and greater patient 
comorbidity. Gram-positive bacteria have been reported 
as accounting for 46% of all SSIs, in all branches of sur-
gery. for hip and knee arthroplasty, among mono-
microbial infections (which account for around 75% of 
all patients), between 30% and 38% were methicillin-
sensitive Staphylococcus (S.) aureus (MSSA), between 
4% and 5% were methicillin-resistant S. aureus (MRSA), 
and between 25% and 28% were coagulase negative 
staphylococci. In polymicrobial cases Gram-positive 
organisms were implicated in between 70% and 80% of 
patients.8 for orthopaedic surgery, Gram-positive 
organisms account for the majority of SSIs.8
high-level nasal carriers of MSSA have a risk of 
healthcare- associated MSSA infection that is three to six 
times the risk compared with noncarriers and low-level 
 carriers 10 and is similar in both surgical and non- 
surgical hospitalized patients.11,12 It is also known that 
more than 80% of healthcare-associated S. aureus infec-
tions are endogenous, implying that acquisition is from 
sites on the patient’s own body.13,14 The association 
between nasal carriage of S. aureus, specifically MRSA, 
and SSI has been demonstrated in a systematic review 
and confirmed in recent cohort studies.15,16
a pan-european study reported that 21.6% of healthy 
european residents carry S. aureus in their nose, with the 
rate in the united Kingdom being 25%, although there 
was wide variation between countries.17 a recent 
retrospective part cohort united Kingdom-based study 
among patients undergoing elective orthopaedic sur-
gery reported a threefold reduction in MSSA-associated 
SSI, using a routine preoperative screening and de -
colonization programme.18 In contrast to MSSA, MRSA 
prevalence in healthy community individuals is esti-
mated to be < 2%.19 Screening of patients presenting for 
surgery or admitted to hospital areas with strong risk fac-
tors for MRSA, such as intensive care units (Icus), dialysis 
units, and elderly care areas, is widely practised in health-
care systems. The National Screening policy for MRSA20 
in the united Kingdom recommends the use of two 
swabs (a nasal swab plus a perineal or throat swab) cul-
tured directly or following pre-enrichment onto chromo-
genic MRSA-selective media. as primary screening media, 
the american Society for microbiology recommends salt-
containing tryptone soya broth (TSB) in conjunction 
with a blood agar plate and mannitol-salt agar (mSa) 
containing 4 µg of oxacillin per millilitre.21 There are cur-
rently no national screening policies for MSSA in the 
united Kingdom or united States prior to orthopaedic 
surgery, despite the recent recommendations from the 
World health organization.22
The aims of this study were to evaluate the diagnostic 
performance of molecular and culture techniques in 
S. aureus screening using paired nasal samples, to deter-
mine the cause of any discrepancy between the diagnos-
tic techniques and to model the potential effect of 
different diagnostic techniques on S. aureus detection in 
orthopaedic patients.
Materials and Methods
Nasal swabs for polymerase chain reaction (Pcr) assay 
and culture of S. aureus were collected from a study pop-
ulation of 273 orthopaedic outpatients due to undergo 
joint arthroplasty surgery at a university teaching hospital 
(royal Infirmary edinburgh) between october 2015 and 
September 2016. The study protocol was reviewed and 
approved by the regional ethics committee (rec 15/
SS/0091). Patients presenting for assessment prior to 
orthopaedic implant surgery were prospectively enrolled 
and provided written consent. all specimens were col-
lected by trained research nurses and were processed 
within three hours of collection. Patient data was 
anonymized, processed, and stored in accordance with 
established guidelines.23
The Xpert S. aureus Nasal complete assay (cepheid, 
Sunnyvale, california) was carried out according to the 
manufacturer’s instructions. Swab tips (Sample collection 
device, cepheid) were placed in elution buffer, vortexed, 
and added to a test cartridge, which was loaded into the 
GeneXpert (cepheid) Instrument. Primers and probes are 
included to detect S. aureus (staphylococcal protein a, 
spa) as well as two markers of methicillin resistance (the 
methicillin resistance gene mecA and the staphylococcal 
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cassette chromosome (Sccmec)). Standard swabs (amies 
Transport Swab, Sarstedt, Nümbrecht, Germany) were 
plated directly to solid agar while enrichment swabs 
(Sigma Tryptic Soy broth with 6.5% Nacl, (medical Wire 
& equipment, corsham, Wiltshire, united Kingdom)) 
were incubated for between18 and 24 hours at 37°c prior 
to plating. To aid detection of both MRSA and MSSA, 
swabs were subbed to Brilliance MRSA 2 agar (Thermo 
fisher Scientific oxoid, Basingstoke, hampshire, united 
Kingdom) and mannitol salt agar (mSa) (Thermo fisher 
Scientific oxoid). culture plates were incubated for 
between 18 and 24 hours at 37°c. after incubation, pre-
sumptive S. aureus colonies (denim blue on chromo-
genic agar or yellow on mSa) were subcultured to 
columbia blood agar (cBa) (Thermo fisher Scientific 
oxoid, Basingstoke, hampshire, uK ) for identification 
using a microflex maldI-Tof mass spectrometer (Bruker 
daltonics, Billerica, massachusetts). for isolates confirmed 
as S. aureus, antibiotic sensitivity testing was performed 
on the vITeK 2 system (biomérieux, marcy-l’Étoile, france) 
using aST P-634 cards. a further Pcr assay was conducted 
in 58 randomly selected samples as part of a discrepant 
analysis. after processing for culture, swabs were held at 
4°c for up to seven days before storing at -80°c. Swabs 
were placed in microtest m4-rT transport medium 
(remel, San diego, california), vortexed for ten seconds, 
and 200 µl of the liquid was stored. Samples were thawed 
and nucleic acid was extracted as previously described.24 
after thawing, the samples were processed using a stand-
ard protocol for real-time Pcr detection of S. aureus 
thermo stable nuclease (nuc) gene using the aBI 7500 fast 
Instrument (applied Biosystems, foster city, california).25
data were analyzed using SPSS statistical software ver-
sion 22.0 (IBm Inc., armonk, New york) and minitab ver-
sion 17.1.0 (minitab ltd, coventry, Warwickshire, united 
Kingdom). fisher’s exact test was used to compare the 
diagnostic performance of each technique. a discrepant 
analysis was performed to determine the cause of any dif-
ference between the estimated prevalence.26 using the 
results of both Pcr assays as the benchmark the perfor-
mance characteristics were calculated. Sensitivity analysis 
was conducted using 95% confidence intervals (cIs) gen-
erated from the paired sample data. a p-value < 0.05 was 
deemed to be statistically significant.
using data reported in the literature, the risk of 
S. aureus SSI in patients with known nasal colonization, 
the risk reduction associated with a preoperative MSSA 
screening and eradication, and annual rates of joint 
arthroplasty surgery were estimated. These estimates 
were combined with the diagnostic performance charac-
teristics from the paired nasal samples to model the effect 
discrepancies in diagnostic performance would have on 
national MSSA SSI incidence.
Results
In the 273 patients undergoing nasal screening, the 
median age was 68 years (interquartile range (IQr) 61 
to 75), 176 of whom were female (64.5%). of these 
patients, 239 (87.6%) were due to undergo primary hip 
or knee arthroplasty. from the initial 273 paired sam-
ples, a total of 16 sample pairs (5.9%) were excluded 
due to Xpert assay failure (n = 9, 3.3%) or failure to per-
form culture as per study protocol (n = 7, 2.6%), leaving 
257 paired samples available for analysis. The results of 
the Pcr and culture assays are shown in Table I. The 
Xpert Pcr assay found 37.9% of samples to be positive 
(95% confidence interval (cI) 32.0 to 44.0), with 35.6% 
MSSA (95% cI 29.8 to 41.7) and 2.3% MRSA (95% cI 0.8 
to 4.9). direct culture found 23.6% of samples to be 
positive (95% cI 17.4 to 30.9), with 22.4% (95% cI 16.3 
to 29.6) and 1.2% (95% cI 0.1 to 4.3) confirmed as 
MSSA and MRSA, respectively. Pre-enriched culture 
found 33.7% of samples to be positive (95% cI 24.2 to 
44.3), with 30.4% MSSA (95% cI 21.3 to 40.9) and 4.3% 
MRSA (95% cI 1.2 to 10.8).
a summary of the performance characteristics taken 
from the 58 paired samples that underwent both Pcr 
assays and either direct or pre-enriched culture is shown 
in Table I. analysis of the data suggested that the cause of 
the discrepancy was due to a lack of sensitivity associated 
with direct culture.
The absolute difference in estimated prevalence of 
nasal MSSA colonization between the Pcr assay and 
direct culture was 13.1% (95% cI 4.6 to 21.8), which was 
statistically significant (p = 0.005). exclusive use of direct 
culture would estimate the MSSA prevalence 8.0% 
(95% cI 3.3 to 19.4) lower than pre-enriched culture, 
which was not statistically significant (p = 0.167)
table I. complete results of Xpert Pcr assay, direct culture, and pre-enrichment culture for Staphylococcus aureus nasal screening
Assay Positive, n (%) negative, n (%) Result not available
 MSSA MRSA total  
Xpert Pcr assay (n = 273) 94 (35.6) 6 (2.3) 100 (37.9) 164 (62.1) 9*
direct culture (n = 181) 37 (22.4) 2 (1.2) 39 (23.6) 126 (76.4) 16†
Pre-enrichment culture (n = 92) 28 (80.0) 3 (8.6) 31 (88.6) 4 (11.4) 57‡
*Invalid result by Xpert Pcr
†culture not performed in line with study protocol
‡enrichment not performed on Xpert Pcr negative samples
MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; Pcr, polymerase chain reaction
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It is estimated that almost 1 200 000 primary joint 
arthroplasties are performed annually in the united States 
and united Kingdom combined (Table II).27-29 If direct 
culture were to be used exclusively over Pcr or pre-
enriched culture in the united Kingdom and the united 
States, approximately 96 200 to 156 000 such patients 
with nasal MSSA colonization would be missed (Table II). 
It has previously been reported that nasal S. aureus colo-
nization has an absolute risk of S. aureus SSI of 7.7% in 
elective orthopaedic patients (95% cI 5.4 to 10.8).30 
S. aureus screening and eradication programmes prior to 
elective orthopaedic surgery have a reported relative risk 
reduction of 66.4% (95% cI 45.8 to 87.0) for the preven-
tion of S. aureus SSI.18,30-34 according to economic esti-
mates in the united States, the hospital treatment costs 
for an individual patient with prosthetic joint infection 
(PJI) range from $30 000 to $120 000.35-37 estimates in 
the united Kingdom for total hospital care costs per case 
are similar to that in the united States (between £20 000 
and £100 000).38,39 Therefore, 4860 to 7900 S. aureus 
SSIs could potentially be prevented, and approximately 
$140 million to $950 million (approximately £110 million 
to £760 million) saved in treatment costs in the united 
Kingdom and the united States combined, by using Pcr 
or enrichment culture, rather than direct culture in 
S. aureus screening programmes (Table II).
Discussion
This study provides the first evaluation of the effect that 
different diagnostic methods have on the prevalence of 
nasal MSSA colonization in a united Kingdom elective 
orthopaedic population. using a combination of pub-
lished data and the results of this study, the likely effect 
on S. aureus SSI incidence, if direct culture methods are 
adopted nationally, has been modelled.
The MSSA prevalence in this study was estimated to be 
between 22.4% and 35.6%, depending on the diagnostic 
method, broadly in line with previous studies.18,40-43 
meenan et al40 reported an S. aureus prevalence rate of 
41.7% in a cohort of 204 obstetrics and gynaecology 
patients in Ireland. The prevalence of MSSA and MRSA 
was 40.7% and 1.0%, respectively. Nadimpalli et  al41 
found out of 210 workers exposed to livestock produc-
tion facilities in the uSa, 83 (40%) had nasal S. aureus 
colonization. van vugt et al42 reported a nasal S. aureus 
colonization rate of 40.5% amongst 366 surgeons and 
surgical trainees, compared with a 30.8% prevalence out 
of 950 in a healthy non-hospitalized control group in The 
Netherlands. a recent united Kingdom-wide study of 
elective orthopaedics patients reported an MSSA preva-
lence of 29% using direct culturing techniques alone 
(89 MSSA positive patients of 307 elective patients 
screened).18 In a review of longitudinal studies Wertheim 
et al43 reported that “a mean of about 20% (12% to 30%) 
of individuals are persistent S. aureus nasal carriers, 
approximately a mean of 30% are intermittent carriers 
(16% to 70%) and about 50% (16% to 69%) are non- 
carriers”. It is likely that the S. aureus carriers in this study 
represent a mix of persistent and intermittent carriers 
who have been in contact with health care facilities, 
which may explain the higher prevalence rate.
The performance characteristics of the Pcr assay and 
pre-enriched culture were found to be similar in this 
study. Both techniques were found to be more sensitive 
than direct culture in the detection of nasal MSSA. There 
was increased cost for consumables and processing of 
the Pcr assay (£28/$35) compared with pre-enriched 
culture (£14/$18) and direct culture (£13/$16). Previous 
studies have reported mixed performance characteristics 
when comparing Pcr to culture techniques. andriesse 
et  al44 reported a lower sensitivity for two Pcr assays 
(82.0% and 85.6%) in comparison to a pre-enriched 
semi-quantitative culture technique (98.2%) in the detec-
tion of MSSA nasal colonization when using pre-enriched 
conventional culture as a benchmark. Wassenberg et al45 
performed an evaluation of the Geneohm MRSA (Becton 
dickinson diagnostics, San diego, california) and Gene-
Xpert MRSA Pcr assays, as well as direct culture onto a 
selective, chromogenic agar (MRSA-Id,  biomérieux) using 
direct conventional culture as the reference in the 
table II. Potential prevention of Staphylococcus (S.) aureus surgical site infections in the united Kingdom and united States
Approx. no. of 
PJAs per annum
no. of patients with nasal MSSA 
colonization potentially missed*
no. of preventable 
S. aureus SSIs†
Approx. treatment costs 
potentially saved‡
united States 1 000 000 80 000 to 130 000 4000 to 6600 $120 million to $790 million
england, Wales, and Northern Ireland 182 000 15 000 to 24 000 800 to 1200 $20 million to $150 million§
Scotland 16 000 1200 to 2000 60 to 100 $1.5 million to $12.5 million¶
Total 1 198 000 96 200 to 156 000 4860 to 7900 $141.5 million to $952.5 million
*The approximate number of patients with nasal MSSA colonization who would be missed if direct culture were to be used exclusively over polymerase chain 
reaction or pre-enriched culture
†The number of surgical site infections that could potentially be prevented if polymerase chain reaction or pre-enriched culture were used, rather than direct 
culture, in Staphylococcus aureus screening programmes
‡The approximate amount that could be saved in treatment costs if polymerase chain reaction or pre-enriched culture were used, rather than direct culture, in 
Staphylococcus aureus screening programmes
§converted from GBP (£16 million to £120 million) to uSd at a rate of £1 = $1.25 (the mean GBP to uSd rate for february 2017, rounded to the nearest five 
cents)
¶converted from GBP (£1.2 million to £10 million) to uSd at a rate of £1 = $1.25 (the mean GBP to uSd rate for february 2017, rounded to the nearest five cents)
approx., approximate; PJas, primary joint arthroplasties; SSIs, surgical site infections; Pcr, polymerase chain reaction
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detection of MRSA in non-critical care hospital admissions. 
The Pcr assays were found to have 85.2% and 75.0% 
sensitivity, and 96.5% and 94.5% specificity, respectively. 
direct culture on chromogenic agar had an 85.7% and 
96.6% sensitivity and specificity, respectively.45 a similar 
study was repeated by the same group in dutch Icu 
admissions, with higher sensitivity levels (100%) and sim-
ilar specificity levels (95.7%) associated with the 
GeneXpert MRSA assay. No MRSA were detected using 
the culture technique in this dutch Icu study and thus 
the sensitivity could not be calculated. The specificity of 
culture using chromogenic agar was 93.3%.46 In con-
trast, Bebko et al47 reported a higher detection level with 
Pcr compared with direct culture when they evaluated 
the diagnostic performance of the GeneXpert assay in 
patients prior to undergoing orthopaedic implant sur-
gery. They reported that Pcr assay had a 100% sensitivity 
and 77.1% specificity when used for detection of nasal 
MSSA, when using culture as the benchmark.
Previous comparisons between pre-enrichment and 
direct culture for the recovery of MSSA from clinical sam-
ples have been reported. mcallister et  al48 found that 
enrichment of swabs using TSB increased sensitivity for 
S.  aureus by 13% compared with direct plating when 
using mSa culture medium in 600 hIv-positive outpa-
tients. meenan et al40 reported a 16% increase in sensitiv-
ity with enrichment, using brain-heart infusion, when 
compared to direct plating onto cBa. In the same study, 
enrichment of swabs increased sensitivity for S. aureus by 
31% compared with direct plating onto a selective chro-
mogenic agar (biomérieux S. aureus Id medium agar). In 
our study, enrichment increased the sensitivity for 
S. aureus by 21% compared with direct plating, a greater 
increase than reported by mcallister et al48 in hIv positive 
patients. The sensitivity for the detection of nasal S. aureus 
associated with enrichment of swabs in our study was 
similar to that reported by Nadimpalli et al.41 They found 
enrichment (muellar-hinton broth, 6.5% Nacl) of nasal 
swabs was associated with an 80.7% and 90.4% sensitiv-
ity for S. aureus when using Baird-Parker agar and a chro-
mogenic agar, respectively. They also found reported 
high inter-observer agreement, kappa coefficient 0.69 
(95% cI 0.59 to 0.80), between the two-culture media.41 
despite the favourable performance characteristics of 
both Pcr and enrichment culture, the barriers to univer-
sal uptake have been cost-effectiveness45,49 and increased 
processing time,49,50 respectively.
The main limitation of this study was that Pcr-negative 
samples were not analyzed in the cohort of samples 
undergoing enrichment. This prevented a complete eval-
uation, with receiver operating characteristic analysis, of 
the enrichment technique. The decision not to analyze 
these samples was based on the high specificity (98%) 
demonstrated by the direct plating technique. a further 
limitation was that we compared culture with a test that 
is not a universally accepted gold standard (i.e. combined 
Pcr assays). Pcr detects nucleic acid and does not distin-
guish between dead or live bacteria; as only viable bacte-
ria are detected by culture, it is possible the sensitivities 
we report for culture may be falsely low. however, we 
believe that this is not the case as we show enrichment 
provides a similar sensitivity to Pcr, suggesting that the 
false negatives with direct culture are due to missed low-
level positive samples. data were derived from the litera-
ture during the modelling process, which made it 
necessary to use assumptions that may affect the validity 
of the estimates produced.
In summary, we found the prevalence of MSSA nasal 
colonization was found to be between 22% and 36%. 
The use of Pcr assays or pre-plating enrichment of swabs 
in TSB significantly improves nasal MSSA detection levels, 
which is relevant to both future research and clinical 
practice. These results should be considered when inter-
preting prevalence studies, when evaluating interven-
tional studies, and in the development of future screening 
and decolonization strategies.
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